Status:
COMPLETED
Genicular and Anterior Femoral Cutaneous Nerve Blocks for Total Knee Arthroplasty
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Total Knee Replacement
Genicular Nerve Block
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The goal of this randomized controlled trial is to examine if there is a relationship between the addition of the genicular nerve block and anterior femoral cutaneous nerve block in providing analgesi...
Detailed Description
Adductor canal nerve block (ACB), infiltration between the popliteal artery and the posterior knee capsule (IPACK), with or without peri-articular infiltration of local anesthetics (PAI), is the curre...
Eligibility Criteria
Inclusion
- patients age 18-80
- patients undergoing ambulatory unilateral total knee arthroplasty, including 23 hour stay cohort
- ASA I-III
- BMI \< 35
Exclusion
- history of chronic pain syndromes
- chronic opioid use (daily morphine milligram equivalents \> 30 mg for at least 3 months)
- contraindication to peripheral nerve blocks
- contraindication to neuraxial anesthesia
- history of peripheral neuropathy or pre-existing neurological deficits
- Psychiatrics or cognitive disorder that prohibit patient from following study protocol
- allergy to local anesthetic or study medications
- multiligament surgery
- history of substance abuse
- infection at the site of injection
- chronic kidney disease
- currently taking anticonvulsants
Key Trial Info
Start Date :
June 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 11 2025
Estimated Enrollment :
244 Patients enrolled
Trial Details
Trial ID
NCT05980546
Start Date
June 7 2023
End Date
September 11 2025
Last Update
October 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021